Malonyl-CoA decarboxylase deficiency: Long-term follow-up of a patient new clinical features and novel mutations

2015 ◽  
Vol 37 (1) ◽  
pp. 107-113 ◽  
Author(s):  
Padmini P. Polinati ◽  
Leena Valanne ◽  
Tiina Tyni
Mitochondrion ◽  
2011 ◽  
Vol 11 (4) ◽  
pp. 639
Author(s):  
Padmini P. Polinati⁎ ◽  
Eva Roomets ◽  
Tiina Tyni

2019 ◽  
Vol 128 (1-2) ◽  
pp. 113-121 ◽  
Author(s):  
Cristel Chapel-Crespo ◽  
Dimitar Gavrilov ◽  
Mary Sowa ◽  
Jessica Myers ◽  
Debra-Lynn Day-Salvatore ◽  
...  

2009 ◽  
Vol 15 (4) ◽  
pp. 259-263 ◽  
Author(s):  
Antonella Tosti ◽  
Anna Maria Peluso ◽  
Valeria Zucchelli

Thyroid ◽  
1998 ◽  
Vol 8 (6) ◽  
pp. 517-523 ◽  
Author(s):  
M.E. GIRELLI ◽  
D. NACAMULLI ◽  
M.R. PELIZZO ◽  
D. DE VIDO ◽  
C. MIAN ◽  
...  

2008 ◽  
Vol 126 (2) ◽  
pp. 155-164 ◽  
Author(s):  
Baldassarre Martire ◽  
Roberto Rondelli ◽  
Annarosa Soresina ◽  
Claudio Pignata ◽  
Teresa Broccoletti ◽  
...  

Medicine ◽  
2008 ◽  
Vol 87 (6) ◽  
pp. 301-310 ◽  
Author(s):  
Jeroen C. H. van der Hilst ◽  
Evelien J. Bodar ◽  
Karyl S. Barron ◽  
Joost Frenkel ◽  
Joost P. H. Drenth ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-5
Author(s):  
Zafer Cebeci ◽  
Samuray Tuncer ◽  
Rejin Kebudi

Purpose. The diagnosis and management of retinoblastoma can be difficult in older children. This study reports the clinical features and long-term outcomes of such patients in a Turkish patient population. Methods. Medical records of 18 patients, between January 1992 and December 2017, were reviewed retrospectively. Results. Of 298 consecutive patients with retinoblastoma, 18 (6%) were at the age of 5 years and older. The median age at diagnosis was 9 years (range, 5–18 years). Misdiagnosis was noted in 8 patients (44.4%). Treatment options included enucleation in 16 patients (88.8%), adjuvant systemic chemotherapy in 3 (16.6%), intra-arterial chemotherapy in one (5.5%), and additional orbital irradiation in one (5.5%). After a median follow-up of 97 months (range, 6–252 months), all patients survived without any recurrence. Conclusions. Our series showed that 6% of patients with retinoblastoma were 5 years of age and older. Over a 15-year period, ocular salvage rate of 11.2% and survival rate of 100% were attained.


Sign in / Sign up

Export Citation Format

Share Document